載入...
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea
Drug lag—delayed approval or reimbursement—is a major barrier to accessing cutting‐edge drugs. Unlike approval lag, reimbursement lag is under‐researched. We investigated the key determinants of reimbursement lag under Taiwan National Health Insurance (NHI), and compared this lag with those in the U...
Na minha lista:
| 發表在: | Clin Transl Sci |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485943/ https://ncbi.nlm.nih.gov/pubmed/32166908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12778 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|